+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-Microbial Resistance Market - Global Forecast 2026-2032- Product Image
Anti-Microbial Resistance Market - Global Forecast 2026-2032- Product Image
Sale

Anti-Microbial Resistance Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6140280
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anti-Microbial Resistance Market is projected to reach USD 13.65 Billion in 2026. It is expected to continue growing at a CAGR of 10.27%, reaching USD 24.45 Billion by 2032.

Antimicrobial Resistance: A Global Health and Systems Challenge

Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, or parasites no longer respond effectively to medicines. It can make infections harder to treat, increase the risk of severe illness, and undermine routine medical procedures that depend on effective infection prevention and treatment. The challenge spans human health, animal health, food systems, and the environment, requiring coordinated action across sectors rather than isolated clinical interventions.

One Health Coordination Is Reshaping AMR Responses

AMR strategies are increasingly organized around a One Health framework that links human, animal, plant, and environmental health. Key shifts include stronger antimicrobial stewardship, improved infection prevention and control, expanded vaccination, better sanitation, surveillance of antimicrobial use and resistance, and efforts to reduce inappropriate access and prescribing. Progress depends on connecting laboratories, clinicians, veterinarians, regulators, public-health agencies, and agricultural stakeholders through interoperable systems and shared accountability.

Artificial Intelligence Strengthens Surveillance and Stewardship

Artificial intelligence can support AMR management by detecting patterns in laboratory and prescribing data, helping identify outbreaks, improving diagnostic decision support, and accelerating the analysis of pathogen and genomic information. Its value depends on high-quality, representative datasets, transparent validation, cybersecurity, and careful clinical oversight. AI should complement-not replace-laboratory confirmation, antimicrobial stewardship teams, and public-health judgment, particularly where data gaps could amplify bias or delay appropriate treatment.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America emphasizes antimicrobial stewardship, advanced diagnostics, surveillance integration, and health-system quality improvement. Latin America continues to benefit from stronger laboratory networks, infection prevention, vaccination, and responsible access initiatives. Europe has developed comparatively coordinated surveillance and policy mechanisms, while the Middle East is prioritizing hospital infection control, laboratory capacity, and cross-border coordination. Africa faces persistent constraints in diagnostics, water and sanitation, workforce capacity, and reliable medicine access, making foundational health-system investment essential. Asia-Pacific combines substantial innovation capacity with highly varied regulatory, surveillance, and access conditions, requiring locally adapted One Health programs and regional cooperation.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Can Align Collective Action

ASEAN cooperation is well suited to cross-border surveillance, laboratory networking, and coordinated preparedness. BRICS members can contribute through research collaboration, manufacturing capacity, diagnostics, and shared public-health learning while accounting for diverse health systems. The European Union can reinforce common surveillance, stewardship, and regulatory approaches. G7 members can support financing, research, and global health governance. GCC countries can deepen regional laboratory and hospital preparedness, while NATO can incorporate AMR into resilience, medical readiness, and biological-threat preparedness. Across all groups, practical data sharing and sustained implementation are more valuable than short-term commitments alone.

Country Priorities Span Stewardship, Diagnostics, Surveillance, and Access

Australia can build on integrated One Health surveillance and stewardship. Brazil and Mexico require continued investment in laboratory networks, infection prevention, and equitable access across diverse territories. Canada, the United States, the United Kingdom, France, Germany, Italy, Spain, and Japan can strengthen coordinated surveillance, diagnostics, responsible prescribing, and innovation incentives. China and India have important roles in laboratory capacity, manufacturing quality, stewardship, and large-scale public-health implementation. South Korea can advance digital surveillance, hospital stewardship, and research collaboration. Russia can strengthen monitoring, laboratory interoperability, and responsible antimicrobial use. In every country, national priorities should be adapted to local resistance patterns, health-system capacity, and regulatory conditions.

Leaders Should Make AMR Action Measurable, Integrated, and Locally Implementable

Industry and health-system leaders should establish clear stewardship metrics, connect prescribing data with resistance and outcomes, and expand rapid diagnostic access where it changes treatment decisions. They should invest in infection prevention, vaccination, water and sanitation, workforce training, and quality-assured medicines while embedding animal and environmental surveillance into national plans. Digital and AI tools should undergo independent validation and privacy review. Leaders should also support sustainable research and development pathways, transparent supply chains, responsible manufacturing, and partnerships that improve access without encouraging unnecessary antimicrobial use.

Methodology: Evidence Synthesis Across One Health and Health-System Domains

This executive summary uses a structured qualitative synthesis of established AMR concepts and policy priorities across human, animal, food, and environmental health. The analysis organizes insights by global transformation, AI applications, region, multilateral group, and country, emphasizing surveillance, stewardship, diagnostics, prevention, access, innovation, and governance. It avoids unsupported numerical claims and market-sizing assumptions. Country and group observations are framed as strategic priorities rather than rankings, and recommendations are derived from widely recognized AMR control principles.

Coordinated Prevention and Responsible Use Are Central to AMR Progress

AMR is a complex, cross-border challenge that cannot be addressed through new medicines alone. Durable progress requires prevention, accurate diagnosis, appropriate treatment, effective surveillance, equitable access, and accountability across human, animal, and environmental systems. Regional and international groups can accelerate progress by sharing data, strengthening capacity, and aligning incentives, while national leaders must translate these priorities into measurable, locally workable programs. Artificial intelligence may improve speed and precision, but governance, clinical expertise, and public-health infrastructure remain the foundation of effective action.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Anti-Microbial Resistance Market, by Product Type
7.1. Introduction
7.2. Diagnostics
7.2.1. Imaging
7.2.2. Molecular Diagnostics
7.2.3. Phenotypic Diagnostics
7.3. Drugs
7.3.1. Aminoglycosides
7.3.2. Beta-Lactams
7.3.2.1. Carbapenems
7.3.2.2. Cephalosporins
7.3.2.3. Monobactams
7.3.2.4. Penicillins
7.3.3. Glycopeptides
7.3.4. Macrolides
7.3.5. Tetracyclines
8. Anti-Microbial Resistance Market, by Indication
8.1. Introduction
8.2. Bloodstream Infections
8.3. Respiratory Infections
8.4. Skin And Soft Tissue Infections
8.5. Surgical Site Infections
8.6. Urinary Tract Infections
9. Anti-Microbial Resistance Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.3. Intravenous
9.4. Oral
9.5. Topical
10. Anti-Microbial Resistance Market, by Resistance Mechanism
10.1. Introduction
10.2. Carbapenem Resistant
10.3. Colistin Resistant
10.4. Extended Spectrum Beta Lactamase
10.5. Methicillin Resistant
10.6. Vancomycin Resistant
11. Anti-Microbial Resistance Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Home Care
11.6. Hospitals
12. Anti-Microbial Resistance Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Anti-Microbial Resistance Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Anti-Microbial Resistance Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Accelerate Diagnostics Inc.
16.3. Becton Dickinson and Company
16.4. bioMérieux SA
16.5. Danaher Corporation
16.6. F. Hoffmann-La Roche Ltd
16.7. Fresenius Kabi AG
16.8. Hain Lifescience GmbH
16.9. Otsuka Pharmaceutical Co., Ltd.
16.10. Qiagen N.V.
16.11. Siemens Healthineers AG
16.12. Teva Pharmaceutical Industries Ltd.
16.13. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Anti-Microbial Resistance Market, Years Considered for the Study
FIGURE 2. Global Anti-Microbial Resistance Market, Research Design
FIGURE 3. Global Anti-Microbial Resistance Market, Research Framework
FIGURE 4. Global Anti-Microbial Resistance Market, Data Triangulation
FIGURE 5. Global Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Anti-Microbial Resistance Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Anti-Microbial Resistance Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Anti-Microbial Resistance Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Anti-Microbial Resistance Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Anti-Microbial Resistance Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Anti-Microbial Resistance Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2025 vs 2032 (%)
FIGURE 13. Global Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Anti-Microbial Resistance Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Anti-Microbial Resistance Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Anti-Microbial Resistance Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Anti-Microbial Resistance Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Anti-Microbial Resistance Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Anti-Microbial Resistance Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Anti-Microbial Resistance Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Anti-Microbial Resistance Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Anti-Microbial Resistance Market Segmentation & Coverage
TABLE 2. Global Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 3. Global Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Phenotypic Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Phenotypic Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Phenotypic Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Aminoglycosides Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Aminoglycosides Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Aminoglycosides Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Beta-Lactams Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Beta-Lactams Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Beta-Lactams Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Carbapenems Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Carbapenems Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Carbapenems Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Cephalosporins Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Cephalosporins Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Cephalosporins Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Monobactams Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Monobactams Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Monobactams Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Penicillins Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Penicillins Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Penicillins Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Glycopeptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Glycopeptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Glycopeptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Macrolides Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Macrolides Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Macrolides Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Tetracyclines Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Tetracyclines Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Tetracyclines Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 47. Global Bloodstream Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Bloodstream Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Bloodstream Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Skin And Soft Tissue Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Skin And Soft Tissue Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Skin And Soft Tissue Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Surgical Site Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Surgical Site Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Surgical Site Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Urinary Tract Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Urinary Tract Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Urinary Tract Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 63. Global Inhalation Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Inhalation Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Inhalation Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 76. Global Carbapenem Resistant Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Carbapenem Resistant Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Carbapenem Resistant Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Colistin Resistant Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Colistin Resistant Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Colistin Resistant Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Extended Spectrum Beta Lactamase Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Extended Spectrum Beta Lactamase Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Extended Spectrum Beta Lactamase Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Methicillin Resistant Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Methicillin Resistant Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Methicillin Resistant Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Vancomycin Resistant Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Vancomycin Resistant Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Vancomycin Resistant Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Anti-Microbial Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Anti-Microbial Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. North America Anti-Microbial Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. North America Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. North America Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 120. North America Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 121. North America Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 122. North America Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 123. North America Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 124. North America Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 125. North America Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Latin America Anti-Microbial Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Latin America Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. Latin America Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 129. Latin America Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 130. Latin America Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 131. Latin America Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 132. Latin America Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 133. Latin America Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 134. Latin America Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Europe Anti-Microbial Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Europe Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. Europe Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 138. Europe Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 139. Europe Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 140. Europe Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 141. Europe Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 142. Europe Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 143. Europe Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Middle East Anti-Microbial Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Middle East Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. Middle East Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 147. Middle East Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 148. Middle East Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 149. Middle East Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 150. Middle East Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 151. Middle East Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 152. Middle East Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Africa Anti-Microbial Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Africa Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Africa Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 156. Africa Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 157. Africa Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 158. Africa Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. Africa Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 160. Africa Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 161. Africa Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Global Anti-Microbial Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. ASEAN Anti-Microbial Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. ASEAN Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. ASEAN Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 166. ASEAN Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 167. ASEAN Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 168. ASEAN Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 169. ASEAN Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 170. ASEAN Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 171. ASEAN Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. GCC Anti-Microbial Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. GCC Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. GCC Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 175. GCC Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 176. GCC Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 177. GCC Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 178. GCC Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 179. GCC Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 180. GCC Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. European Union Anti-Microbial Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. European Union Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. European Union Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 184. European Union Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 185. European Union Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 186. European Union Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 187. European Union Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 188. European Union Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 189. European Union Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. BRICS Anti-Microbial Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. BRICS Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. BRICS Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 193. BRICS Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 194. BRICS Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 195. BRICS Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 196. BRICS Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 197. BRICS Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 198. BRICS Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. G7 Anti-Microbial Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. G7 Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. G7 Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 202. G7 Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 203. G7 Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 204. G7 Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 205. G7 Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 206. G7 Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 207. G7 Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. NATO Anti-Microbial Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. NATO Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. NATO Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 211. NATO Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 212. NATO Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 213. NATO Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. NATO Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 215. NATO Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 216. NATO Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Global Anti-Microbial Resistance Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. United States Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 219. United States Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. United States Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 221. United States Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 222. United States Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 223. United States Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 224. United States Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. United States Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 226. United States Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Canada Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 228. Canada Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. Canada Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 230. Canada Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 231. Canada Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 232. Canada Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 233. Canada Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 234. Canada Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 235. Canada Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Mexico Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 237. Mexico Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Mexico Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 239. Mexico Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 240. Mexico Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 241. Mexico Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 242. Mexico Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 243. Mexico Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 244. Mexico Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Brazil Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 246. Brazil Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. Brazil Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 248. Brazil Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 249. Brazil Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 250. Brazil Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 251. Brazil Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 252. Brazil Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 253. Brazil Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. United Kingdom Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 255. United Kingdom Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. United Kingdom Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 257. United Kingdom Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 258. United Kingdom Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 259. United Kingdom Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 260. United Kingdom Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 261. United Kingdom Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 262. United Kingdom Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Germany Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 264. Germany Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. Germany Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 266. Germany Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 267. Germany Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 268. Germany Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 269. Germany Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 270. Germany Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 271. Germany Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. France Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 273. France Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. France Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 275. France Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 276. France Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 277. France Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 278. France Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 279. France Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 280. France Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. Russia Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 282. Russia Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. Russia Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 284. Russia Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 285. Russia Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 286. Russia Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 287. Russia Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 288. Russia Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 289. Russia Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. Italy Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 291. Italy Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. Italy Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 293. Italy Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 294. Italy Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 295. Italy Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 296. Italy Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 297. Italy Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 298. Italy Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Spain Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 300. Spain Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 301. Spain Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 302. Spain Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 303. Spain Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 304. Spain Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 305. Spain Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 306. Spain Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 307. Spain Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. China Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 309. China Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. China Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 311. China Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 312. China Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 313. China Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 314. China Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 315. China Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 316. China Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. India Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 318. India Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 319. India Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 320. India Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 321. India Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 322. India Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 323. India Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 324. India Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 325. India Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. Japan Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 327. Japan Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 328. Japan Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 329. Japan Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 330. Japan Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 331. Japan Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 332. Japan Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 333. Japan Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 334. Japan Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 335. Australia Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 336. Australia Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 337. Australia Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 338. Australia Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 339. Australia Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 340. Australia Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 341. Australia Anti-Microbial Resistance Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 342. Australia Anti-Microbial Resistance Market Size, by Resistance Mechanism, 2017-2032 (USD Million)
TABLE 343. Australia Anti-Microbial Resistance Market Size, by End User, 2017-2032 (USD Million)
TABLE 344. South Korea Anti-Microbial Resistance Market Size, 2017-2032 (USD Million)
TABLE 345. South Korea Anti-Microbial Resistance Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 346. South Korea Anti-Microbial Resistance Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 347. South Korea Anti-Microbial Resistance Market Size, by Drugs, 2017-2032 (USD Million)
TABLE 348. South Korea Anti-Microbial Resistance Market Size, by Beta-Lactams, 2017-2032 (USD Million)
TABLE 349. South Korea Anti-Microbial Resistance Market Size, by Indication, 2017-2032 (USD Million)
TABLE 350. South Korea Anti-Microbial Resistance Market Size, by Route Of Admi

Companies Mentioned

  • Abbott Laboratories
  • Accelerate Diagnostics Inc.
  • Becton Dickinson and Company
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Hain Lifescience GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Carbapenem-Resistant Enterobacteriaceae Infection - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Image

Carbapenem-Resistant Enterobacteriaceae Infection - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • 200 Pages
  • Global
From
Peptide Antibiotics Market - Global Forecast 2026-2032 - Product Image

Peptide Antibiotics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Antibiotic Resistance Market - Global Forecast 2026-2032 - Product Image

Antibiotic Resistance Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Polymyxin B Market Comprehensive Analysis: Antimicrobial Resistance Trends, Value Chain Dynamics, and Strategic Industry Outlook 2026-2031 - Product Image

Polymyxin B Market Comprehensive Analysis: Antimicrobial Resistance Trends, Value Chain Dynamics, and Strategic Industry Outlook 2026-2031

  • Report
  • 126 Pages
  • Global
From
Antimicrobial Therapeutics Market Outlook 2026-2034: Market Share and Growth Analysis - Product Image

Antimicrobial Therapeutics Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.